Respiratory Tract Infection
A respiratory tract infection (RTI) is an infection that affects the airways and lungs, leading to symptoms such as cough, fever, and difficulty breathing. Common types include colds, bronchitis, and pneumonia.
We are testing a new nasal spray for people with COVID-19 or similar symptoms to see if it helps them recover faster and clear the virus. The study will also monitor safety and overall wellbeing during treatment.
Health conditions and diseases that the clinical trial is designed to study and treat.
A respiratory tract infection (RTI) is an infection that affects the airways and lungs, leading to symptoms such as cough, fever, and difficulty breathing. Common types include colds, bronchitis, and pneumonia.
COVID-19 is a viral infection caused by the coronavirus SARS-CoV-2, leading to symptoms like fever, cough, and difficulty breathing. It can range from mild to severe and may require hospitalization.
COVID-like illness refers to symptoms that resemble those of COVID-19, often caused by various viruses. Symptoms may include fever, cough, and fatigue, but testing is needed to confirm the specific cause.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.